Security Reports > Nektar Therapeutics

Nektar Therapeutics
Data Breaches, Cyber Attacks and Security Report

https://nektar.com  ᛫  Biotech & Pharmaceuticals
Last updated July 12, 2020

Nektar Therapeutics Security Rating

${grade.letter}
${cstarScore}
/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Nektar Therapeutics is implementing good security practices.

Company Information

Company:
${companyName}
Valuation:
${marketCap}
Employees:
${employees}
Location:
${country}
CEO:
${ceo}

About Nektar Therapeutics

Nektar Therapeutics (Nektar) is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances.


Data Breaches and Security News


Security Report for Nektar Therapeutics

Want a security rating for your organization?

This report shows a preliminary security rating for Nektar Therapeutics. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Nektar Therapeutics's security performance with other companies